CAT No: Q-OS-0034
CAS No: 1135616-49-7
Synonyms/Alias: Fmoc-Arg(Me,pbf)-OH;1135616-49-7;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-5-[[N'-methyl-N-[(2,2,4,6,7-pentamethyl-3H-1-benzofuran-5-yl)sulfonyl]carbamimidoyl]amino]pentanoic acid;L-Ornithine, N5-[[[(2,3-dihydro-2,2,4,6,7-pentamethyl-5-benzofuranyl)sulfonyl]amino](methylimino)methyl]-N2-[(9H-fluoren-9-ylmethoxy)carbonyl]-;MFCD08064312;Fmoc-Arg(Me)(Pbf)-OH;DTXSID10855649;AKOS016002157;AKOS030212555;AKOS032961316;AKOS037644148;AS-47147;CS-0005659;F12308;(2S)-2-{[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]AMINO}-5-[(Z)-N''-METHYL-N'-(2,2,4,6,7-PENTAMETHYL-3H-1-BENZOFURAN-5-YLSULFONYL)CARBAMIMIDAMIDO]PENTANOIC ACID;(2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-5-[N''-methyl-N'-(2,2,4,6,7-pentamethyl-3H-1-benzofuran-5-ylsulfonyl)carbamimidamido]pentanoic acid;(E)-N2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-Nw'-methyl-Nw-((2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-yl)sulfonyl)-L-arginine;(S,E)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-(((methylamino)(2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran-5-sulfonamido)methylene)amino)pentanoic acid;N-alpha-(9-Fluorenylmethoxycarbonyl)-N-omega-methyl-N-omega'-(2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl)-L-arginine;N~2~-{[(9H-Fluoren-9-yl)methoxy]carbonyl}-N~5~-[N'-methyl-N-(2,2,4,6,7-pentamethyl-2,3-dihydro-1-benzofuran-5-sulfonyl)carbamimidoyl]-L-ornithine;
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C35H42N4O7S |
M.W/Mr. | 662.8 |
Application | Peptide synthesis; Drug screening |
Purity | 97%min |
InChI | InChI=1S/C35H42N4O7S/c1-20-21(2)31(22(3)27-18-35(4,5)46-30(20)27)47(43,44)39-33(36-6)37-17-11-16-29(32(40)41)38-34(42)45-19-28-25-14-9-7-12-23(25)24-13-8-10-15-26(24)28/h7-10,12-15,28-29H,11,16-19H2,1-6H3,(H,38,42)(H,40,41)(H2,36,37,39)/t29-/m0/s1 |
InChI Key | JAUPJPAADXVUGQ-LJAQVGFWSA-N |
1. TMEM16F and dynamins control expansive plasma membrane reservoirs
3. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
4. Implications of ligand-receptor binding kinetics on GLP-1R signalling
5. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.
USA
Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-624-4882
Fax: 1-631-614-7828
Email: info@creative-peptides.com
Germany
Address: Industriepark Höchst, Gebäude G830
65929 Frankfurt am Main
Email: info@creative-peptides.com